(Q40739742)

23 September 2017

Molecular markers for predicting prostate cancer stage and survival (English)

1 reference

23 September 2017

6

Eeles RA

1 reference

23 September 2017

Dunsmuir WD

1

1 reference

23 September 2017

Gillett CE

2

1 reference

23 September 2017

Meyer LC

3

1 reference

23 September 2017

Young MP

4

1 reference

23 September 2017

Corbishley C

5

1 reference

23 September 2017

Kirby RS

7

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

23 September 2017

1 reference

23 September 2017

86

1 reference

23 September 2017

869-878

1 reference

23 September 2017

7

1 reference

An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer

23 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: a retrospective immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

BRCA2 mutation in Icelandic prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

An enhanced prognostic system for clinically localized carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

Natural history of progression after PSA elevation following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

Prostate-specific antigen and prognosis in patients with metastatic prostate cancer--a multivariable analysis of prostate cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

Immunohistochemical study of p21WAF1 and p53 proteins in prostatic cancer and their prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

The cadherin cell-cell adhesion pathway in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00916.X

10.1046/J.1464-410X.2000.00916.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference